BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34552353)

  • 1. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis.
    Gao L; Li Q
    Cancer Manag Res; 2021; 13():7175-7186. PubMed ID: 34552353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis.
    Wu D; Yin Z; Ji Y; Li L; Li Y; Meng F; Ren X; Xu M
    Sci Rep; 2021 Apr; 11(1):8069. PubMed ID: 33850225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer.
    Lia T; Shao Y; Regmi P; Li X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 35024796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Costimulatory Molecule-Related lncRNAs Associated With Gastric Carcinoma Progression: Evidence From Bioinformatics Analysis and Cell Experiments.
    Yin Z; Qiao Y; Shi J; Bu L; Ao L; Tang W; Lu X
    Front Genet; 2022; 13():950222. PubMed ID: 35991571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer.
    Yang X; Weng X; Yang Y; Jiang Z
    Front Genet; 2021; 12():792106. PubMed ID: 35360412
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer.
    Tan M; Huang G; Chen J; Yi J; Liu X; Liao N; Hu Y; Zhou W; Guo Q
    Am J Transl Res; 2022; 14(5):2779-2800. PubMed ID: 35702100
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang L; Zhang X; Zhao W; Xiao X; Liu S; Peng Q; Jiang N; Zhou B
    Front Med (Lausanne); 2022; 9():760722. PubMed ID: 35308537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
    Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
    Front Oncol; 2020; 10():597569. PubMed ID: 33614483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer.
    Mo X; Hu D; Li Y; Nai A; Ma F; Bashir S; Jia G; Xu M
    Front Genet; 2022; 13():936305. PubMed ID: 36003338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer.
    Zhang K; Ping L; Du T; Liang G; Huang Y; Li Z; Deng R; Tang J
    Front Mol Biosci; 2021; 8():678877. PubMed ID: 34164433
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Value of Genomic Instability of m
    Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.
    Liu ZK; Wu KF; Zhang RY; Kong LM; Shang RZ; Lv JJ; Li C; Lu M; Yong YL; Zhang C; Zheng NS; Li YH; Chen ZN; Bian H; Wei D
    Front Oncol; 2022; 12():794034. PubMed ID: 35311105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
    Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
    Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
    Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
    Front Genet; 2021; 12():569318. PubMed ID: 33796128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.